These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26689790)

  • 1. Novel targeted therapeutics for mantle cell lymphoma--what's on the horizon?
    El Halabi L; Ghez D; Ribrag V
    Expert Rev Hematol; 2016 Mar; 9(3):271-81. PubMed ID: 26689790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).
    Dawar R; Hernandez-Ilizaliturri F
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mantle Cell Lymphoma -  Cutting edge Dia-gnostics and Treatment Approaches].
    Klener P; Trněný M
    Klin Onkol; 2015; 28 Suppl 3():3S80-6. PubMed ID: 26489506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies.
    Nastoupil LJ; Koff JL; Flowers CR
    Oncology (Williston Park); 2013 Oct; 27 Suppl 2():8-12. PubMed ID: 25374999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mantle Cell Lymphoma.
    Cheah CY; Seymour JF; Wang ML
    J Clin Oncol; 2016 Apr; 34(11):1256-69. PubMed ID: 26755518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment for mantle cell lymphoma].
    Izutsu K
    Rinsho Ketsueki; 2017; 58(10):2026-2032. PubMed ID: 28978845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel agents in mantle cell lymphoma.
    Kumar A
    Curr Oncol Rep; 2015 Aug; 17(8):34. PubMed ID: 26045130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel agents in mantle cell lymphoma.
    Tucker D; Rule S
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):491-506. PubMed ID: 28480764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantle cell lymphoma: advances in biology and therapy.
    Smith MR
    Curr Opin Hematol; 2008 Jul; 15(4):415-21. PubMed ID: 18536582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-κB signaling and its relevance to the treatment of mantle cell lymphoma.
    Balaji S; Ahmed M; Lorence E; Yan F; Nomie K; Wang M
    J Hematol Oncol; 2018 Jun; 11(1):83. PubMed ID: 29907126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging therapies in mantle cell lymphoma.
    Brett LK; Williams ME
    Curr Treat Options Oncol; 2013 Jun; 14(2):198-211. PubMed ID: 23512567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice.
    Avivi I; Goy A
    Clin Cancer Res; 2015 Sep; 21(17):3853-61. PubMed ID: 26059189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current therapeutic strategies for mantle cell lymphoma].
    Dreyling M; Schnaiter A; Schmidt C; Hoster E
    Internist (Berl); 2016 Mar; 57(3):230-7. PubMed ID: 26886710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular pathogenesis of mantle cell lymphoma.
    Vogt N; Dai B; Erdmann T; Berdel WE; Lenz G
    Leuk Lymphoma; 2017 Jul; 58(7):1530-1537. PubMed ID: 27894215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapeutic targets in mantle cell lymphoma.
    Martin P; Leonard JP
    Expert Opin Ther Targets; 2007 Jul; 11(7):929-40. PubMed ID: 17614761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mantle cell lymphoma: Towards a personalized therapeutic strategy?].
    Navarro Matilla B; García-Marco JA
    Med Clin (Barc); 2015 Jun; 144(12):553-9. PubMed ID: 25023849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of targeted therapies for mantle cell lymphoma.
    Chang JE; Kahl BS
    Drugs; 2011 Dec; 71(17):2307-26. PubMed ID: 22085387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Cytotoxicity of Lenalidomide and Dexamethasone in Mantle Cell Lymphoma via Cereblon-dependent Targeting of the IL-6/STAT3/PI3K Axis.
    Ma J; Wu K; Bai W; Cui X; Chen Y; Xie Y; Xie Y
    EBioMedicine; 2017 Jun; 20():70-78. PubMed ID: 28529032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle cell lymphoma: the promise of new treatment options.
    Goy A; Kahl B
    Crit Rev Oncol Hematol; 2011 Oct; 80(1):69-86. PubMed ID: 21168343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.